|
|
Volumn 22, Issue 2, 2008, Pages 89-104
|
|
Fungal infections after lung transplantation
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPHOTERICIN B;
AMPHOTERICIN B CHOLESTEROL SULFATE;
AMPHOTERICIN B DEOXYCHOLATE;
AMPHOTERICIN B LIPID COMPLEX;
ANIDULAFUNGIN;
ANTIFUNGAL AGENT;
CASPOFUNGIN;
CYCLOSPORIN;
ECHINOCANDIN;
FLUCONAZOLE;
FLUCYTOSINE;
IMMUNOMODULATING AGENT;
MICAFUNGIN;
POSACONAZOLE;
RAVUCONAZOLE;
RIFAMPICIN;
TERBINAFINE;
TRIAZOLE DERIVATIVE;
VORICONAZOLE;
ANTIBIOTIC RESISTANCE;
ARTICLE;
ASPERGILLOSIS;
ASPERGILLUS;
BLOOD TOXICITY;
CANDIDA;
CANDIDIASIS;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CRYPTOCOCCOSIS;
DRUG BIOAVAILABILITY;
DRUG COST;
DRUG MECHANISM;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
FUSARIUM;
GASTROINTESTINAL SYMPTOM;
HUMAN;
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
INFECTION RISK;
LIVER TOXICITY;
LUNG INSUFFICIENCY;
LUNG TRANSPLANTATION;
MORTALITY;
MUCORMYCOSIS;
MYCOSIS;
NEPHROTOXICITY;
OPPORTUNISTIC INFECTION;
SCEDOSPORIUM;
SKIN TOXICITY;
VISUAL DISORDER;
ANTIFUNGAL AGENTS;
ASPERGILLOSIS;
CANDIDIASIS;
HUMANS;
LUNG DISEASES, FUNGAL;
LUNG TRANSPLANTATION;
POSTOPERATIVE COMPLICATIONS;
RISK FACTORS;
|
|
EID: 40649121066
PISSN: 0955470X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.trre.2007.12.007 Document Type: Article |
|
Times cited : (73)
|
|
References (121)
|
